Invention Grant
- Patent Title: Indazolyl- and indolyl-benzamide derivatives
-
Application No.: US14851542Application Date: 2015-09-11
-
Publication No.: US10246421B2Publication Date: 2019-04-02
- Inventor: Philip F. Hughes
- Applicant: ESANEX, INC.
- Applicant Address: US IN Indianapolis
- Assignee: Esanex, Inc.
- Current Assignee: Esanex, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: C07D231/54
- IPC: C07D231/54 ; C07D409/12 ; C07D405/12 ; C07D401/12 ; C07D403/12 ; A61K31/416 ; A61P35/00 ; A61P29/00
Abstract:
The invention relates to indazolylbenzamide, indolylbenzamide, benzo[d]imidazolyl-benzamide, and benzo[d]triazolylbenzamide derivatives of formula useful in the treatment and/or prevention of diseases and/or conditions related to cell proliferation, such as cancer, infection, inflammation and inflammation-associated disorders, and conditions associated with angiogenesis.
Public/Granted literature
- US20160075662A1 INDAZOLYL- AND INDOLYL-BENZAMIDE DERIVATIVES Public/Granted day:2016-03-17
Information query
